| Erin Elisabeth Amantia, | |
|
319 Washington Crossing Pe Rd, Titusville, NJ 08560-1515 | |
| (609) 647-2706 | |
| Not Available |
| Full Name | Erin Elisabeth Amantia |
|---|---|
| Gender | Female |
| Speciality | Registered Nurse |
| Location | 319 Washington Crossing Pe Rd, Titusville, New Jersey |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1154194462 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163W00000X | Registered Nurse | 837075 (New York) | Secondary |
| 163W00000X | Registered Nurse | 26NR20063400 (New Jersey) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Erin Elisabeth Amantia, 319 Washington Crossing Pe Rd, Titusville, NJ 08560-1515 Ph: (609) 647-2706 | Erin Elisabeth Amantia, 319 Washington Crossing Pe Rd, Titusville, NJ 08560-1515 Ph: (609) 647-2706 |
News Archive
Obama took a risk and proposed a budget containing cuts to entitlements cherished by his party. House Budget Committee Chairman Paul Ryan, a Wisconsin Republican, and his cohorts were unmoved; they wouldn't give an inch on new revenue. Simpson and Bowles gave Obama a pat on the back and largely refrained from criticizing Ryan or House Speaker John Boehner, while corporate leaders ducked.
Taking time out of the work week for an employee exercise program may lead to increased productivity—despite the reduction in work hours, reports a study in the August Journal of Occupational and Environmental Medicine, official publication of the American College of Occupational and Environmental Medicine.
Physicians at the Jefferson Hospital for Neuroscience (JHN), the region's only dedicated hospital for neuroscience, are tackling a particularly aggressive brain cancer that even surgery, chemotherapy and radiation often fail to treat with a promising new immunotherapy to attack a patient's tumor with their own cancer cells.
Shire Canada Inc., a division of Shire plc, the global specialty biopharmaceutical company, is proud to announce that MEZAVANT® (mesalamine delayed and extended release tablets), the first and only once-daily mesalamine indicated for the induction of clinical and endoscopic remission in patients with mild-to-moderate, active ulcerative colitis (UC), has received an expanded indication to include maintenance of clinical and endoscopic remission (mucosal healing) in patients with ulcerative colitis.
› Verified 4 days ago
Sathyamma David, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 14 Pennington-washington Crossing Rd., Titusville, NJ 08560 Phone: 800-950-6066 |